These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38696488)

  • 1. Click Chemistry-Based Force Spectroscopy Revealed Enhanced Binding Dynamics of Phosphorylated HMGB1 to Cisplatin-DNA.
    Liu Y; Song D; Li S; Guo Z; Zheng P
    J Am Chem Soc; 2024 May; 146(19):13126-13132. PubMed ID: 38696488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of in vivo post-translational modifications of the HMGB1 protein upon binding to platinated DNA: a molecular simulation study.
    Lv WL; Arnesano F; Carloni P; Natile G; Rossetti G
    Nucleic Acids Res; 2018 Dec; 46(22):11687-11697. PubMed ID: 30407547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational metallomics of the anticancer drug cisplatin.
    Calandrini V; Rossetti G; Arnesano F; Natile G; Carloni P
    J Inorg Biochem; 2015 Dec; 153():231-238. PubMed ID: 26490711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
    Park S; Lippard SJ
    Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-sensitive structural change in the A-domain of HMGB1 and its implication for the binding to cisplatin modified DNA.
    Wang J; Tochio N; Takeuchi A; Uewaki J; Kobayashi N; Tate S
    Biochem Biophys Res Commun; 2013 Nov; 441(4):701-6. PubMed ID: 24427810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can the cisplatin analogs with different amine act on DNA during cancer treatment theoretically?
    Rahiminezhad A; Moghadam ME; Divsalar A; Mesbah AW
    J Mol Model; 2021 Dec; 28(1):2. PubMed ID: 34874466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
    Jung Y; Lippard SJ
    Biochemistry; 2003 Mar; 42(9):2664-71. PubMed ID: 12614161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Interactions of High-Mobility Group of Protein Domain B1 with DNA Adducts Generated by Platinum Anticancer Molecules Using In Silico Approaches.
    Misra G; Gupta S; Jabalia N
    Interdiscip Sci; 2018 Sep; 10(3):476-485. PubMed ID: 27900730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HMGB1 binding on the structural alterations of platinum drug-treated single dsDNA molecule.
    Mondal S; Banerjee S; Dey D; Lahiri H; Mana T; Jana SS; Mukhopadhyay R
    Biochimie; 2023 Oct; 213():168-175. PubMed ID: 37211256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Autoinhibition of the HMGB1 Protein via Electrostatic Fuzzy Interactions of Intrinsically Disordered Regions.
    Wang X; Greenblatt HM; Bigman LS; Yu B; Pletka CC; Levy Y; Iwahara J
    J Mol Biol; 2021 Sep; 433(18):167122. PubMed ID: 34181980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation by Protein Kinase C Weakens DNA-Binding Affinity and Folding Stability of the HMGB1 Protein.
    Wang X; Holthauzen LMF; Paz-Villatoro JM; Bien KG; Yu B; Iwahara J
    Biochemistry; 2024 Jul; 63(14):1718-1722. PubMed ID: 38916994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
    Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V
    Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of platinum-DNA adducts by HMGB1a.
    Ramachandran S; Temple B; Alexandrova AN; Chaney SG; Dokholyan NV
    Biochemistry; 2012 Sep; 51(38):7608-17. PubMed ID: 22950413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-histone protein HMGB1 inhibits the repair of damaged DNA by cisplatin in NIH-3T3 murine fibroblasts.
    Yusein-Myashkova S; Ugrinova I; Pasheva E
    BMB Rep; 2016 Feb; 49(2):99-104. PubMed ID: 24325815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The repair capacity of lung cancer cell lines A549 and H1299 depends on HMGB1 expression level and the p53 status.
    Yusein-Myashkova S; Stoykov I; Gospodinov A; Ugrinova I; Pasheva E
    J Biochem; 2016 Jul; 160(1):37-47. PubMed ID: 26896489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
    Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
    Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules.
    Lai KK; Chan KT; Choi MY; Wang HK; Fung EY; Lam HY; Tan W; Tung LN; Tong DK; Sun RW; Lee NP; Law S
    Tumour Biol; 2016 Feb; 37(2):2127-36. PubMed ID: 26346170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding interaction of HMGB4 with cisplatin-modified DNA.
    Park S; Lippard SJ
    Biochemistry; 2012 Aug; 51(34):6728-37. PubMed ID: 22901013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale.
    Shu X; Xiong X; Song J; He C; Yi C
    Angew Chem Int Ed Engl; 2016 Nov; 55(46):14246-14249. PubMed ID: 27736024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomic level rendering of DNA-drug encounter.
    Lucas MF; Cabeza de Vaca I; Takahashi R; Rubio-Martínez J; Guallar V
    Biophys J; 2014 Jan; 106(2):421-9. PubMed ID: 24461017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.